This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

New Release Of Accelrys Electronic Lab Notebook Transforms Laboratory Operations

Stocks in this article: ACCL

SAN DIEGO, May 20, 2013 /PRNewswire/ --  Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the latest release of the Accelrys Electronic Lab Notebook (AELN), which now offers extensive integration with the unifying, scientifically aware Accelrys Enterprise Platform (AEP). Expanded integration with AEP supports the management and orchestration of information, data, people, tasks and processes within and across labs, enhancing collaboration, externalization, chemistry harmonization, instrument integration, experiment design and reporting.


"LEO Pharma is using the Accelrys Lab Notebook to support execution and documentation of medicinal chemistry experiments, both single-compound and parallel synthesis," said Dr. Ulrik de Lichtenberg, head of research informatics and data management at LEO Pharma. "We have extended the functionality of the core ELN product by leveraging the Accelrys Enterprise Platform to create an electronic process exactly matched to our scientific workflows. The ELN platform has strengthened our internal knowledge sharing, and at the same time provided us with a seamless process for capturing documentation needed to obtain and defend patents."  

As a key application within the Accelrys Process Management and Compliance Suite of software products, the latest release of the Accelrys Electronic Lab Notebook also offers significant synthetic chemistry enhancements and full integration of interactive Pipeline Pilot scientific authoring protocols that speed data access, review and analysis for medicinal, analytical, formulations and process scientists using the notebook.

The AEP provides a broad, secure foundation supporting tighter integration of the latest notebook release with other applications within the Accelrys Process Management and Compliance Suite and with the platform's extensive scientific Component Collections. The integration with the Accelrys Enterprise Platform has been greatly expanded in this latest notebook release, providing industry-leading data analysis and reporting capabilities that deliver improved experiment insight and productivity for virtually any scientific discipline with lower cost of ownership. For example, the platform speeds experiment design and analysis by enabling scientists to register chemical and biological entities directly within the AELN using the Accelrys Chemical Registration or Accelrys Biological Registration applications.

"The latest release of the Accelrys Electronic Lab Notebook moves beyond the paperless lab to a better connected, more harmonized and compliant lab ecosystem extending from research to manufacturing," said Ken Rapp, managing director of Accelrys' analytical, development, quality and manufacturing solutions. "Improved handling of chemistry workflows in accordance with the way bench chemists actually perform their research speeds lab productivity, while automated Pipeline Pilot workflows within the Notebook accelerate product development in Chemistry, Manufacturing and Control."

The latest release of the Accelrys Electronic Lab Notebook also offers significant enhancements to overall usability and synthetic chemistry for medicinal, analytical, formulations and process scientists including:

  • Improved parallel chemistry supporting medicinal chemists' workflows with step-by-step enumeration on multi-step reaction schemes and salt stripping from enumerated products
  • Flexible, intuitive reaction scaling for both single-step and multiple-step reactions, requiring just two mouse clicks to visualize scaling impact
  • Enhanced experiment cloning keeps experiments compliant with latest SOPs and templates, improving experiment management and administration
  • Better management of favorite materials and faster experiment design through easier access to commonly used reagents and solvents

Join us in Princeton, NJ on June 4-5 at the 2013 Accelrys Process Management & Compliance Suite User Conference and hear Accelrys Electronic Lab Notebook use cases from Pfizer, Colgate Palmolive, Johnson & Johnson, BMS and more.

Gartner rates Accelrys Electronic Lab Notebook "Very High" or "High" in domain expertise across six major scientific disciplines. Download the Gartner Report "Manufacturers Must Consider Scientific Domain Expertise During ELN Selection."

About Accelrys, Inc.

Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad and flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs